SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

OMASS (OMASS) News

Follow OMASS (OMASS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol OMASS Asset market Sector Markets 90 days 1 Updated Oct 15, 2026, 03:04 PM UTC Open live news feed
L OMass raises $310 million in Series C financing with Sanofi Ventures participation OMass Therapeutics announced an oversubscribed $310 million (£230 million) Series C financing on October 15, 2026. The biotechnology company develops small-molecule therapeutics in endocrinology and immunology. Bain Capi NEWS | Oct 15, 2026, 03:04 PM UTC